Research Article
Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer
Table 2
Associations of FEV expression with clinicopathological parameters of patients with PCa.
| | Clinical features | IRS of FEV protein in TMA () | | Cases | | |
| | Age (years) | | <66 | 19 | | 0.114 | | ≥66 | 83 | | | Serum PSA levels (ng/ml) | | <4 | — | — | — | | ≥4 | — | — | | Gleason score | | <7 | 57 | | 0.023 | | ≥7 | 45 | | | Pathological stage | | <T3A | 56 | | 0.015 | | ≥T3A | 46 | | | PSA failure | | Negative | — | — | — | | Positive | — | — | | Metastasis | | No | — | — | — | | Yes | — | — | | Overall survival | | Alive | — | — | — | | Died | — | — |
|
|
